Q1 2023 Holdings
Filed 2023-05-15 | 12 holdings | $241.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $70.6M | 220,000 | 29.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $28.0M | 622,829 | 11.6% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $25.9M | 1,018,474 | 10.7% |
| Merus N V | COM | N5749R100 | $22.5M | 1,225,109 | 9.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $17.8M | 601,325 | 7.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $17.2M | 628,941 | 7.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $15.7M | 831,014 | 6.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $12.8M | 637,526 | 5.3% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $9.2M | 242,848 | 3.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.9M | 24,000 | 3.7% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.1M | 1,312,233 | 3.4% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $4.4M | 4,552,876 | 1.8% |